SPWONE III LTD

Company number 13455166 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SPWONE III LTD - Analysis Report

Company Number: 13455166

Analysis Date: 2025-07-20 18:23 UTC

Financial Health Assessment of SPWONE III LTD


1. Financial Health Score: D

Explanation:
SPWONE III LTD shows significant financial distress symptoms despite having large fixed assets. The company carries a net liability (negative net assets) position, indicating insolvency on a balance sheet basis. While fixed assets are substantial (£25 million), current liabilities nearly match fixed assets, and net current assets are negative, suggesting ongoing liquidity challenges. The persistent negative shareholders' funds and net liabilities over multiple years signal chronic financial imbalance. This warrants a cautious financial health grade of D, reflecting serious concerns that require urgent attention.


2. Key Vital Signs

Metric Value (2023) Interpretation
Fixed Assets £25,000,000 Very high long-term asset base ("solid skeleton")
Current Assets £331,300 Low short-term assets ("limited blood flow")
Current Liabilities £337,800 Current debts exceed current assets ("short-term strain")
Net Current Assets -£6,500 Negative working capital ("cash flow congestion")
Total Assets Less Current Liabilities £24,993,500 After current liabilities, substantial asset value remains
Long-Term Liabilities £24,999,999 Almost equal to fixed assets ("heavy debt burden")
Net Assets (Shareholders Funds) -£6,499 Negative net worth ("financial distress symptom")
Share Capital £10 Minimal equity base ("weak financial immune system")
  • Liquidity: Negative net current assets indicate inability to cover short-term obligations comfortably, a sign of "cash flow congestion."
  • Solvency: Negative net assets highlight insolvency on a balance sheet basis, a critical "organ failure" sign in financial health.
  • Leverage: Extremely high debt relative to assets (almost 100% leverage), indicating a heavy "debt burden" that compromises resilience.
  • Equity Base: Very low share capital and negative retained earnings show weak "financial immunity."

3. Diagnosis

SPWONE III LTD exhibits classic symptoms of financial distress:

  • Despite a strong fixed asset base (£25 million), the company is highly leveraged with long-term liabilities nearly equal to assets.
  • Negative net assets and shareholders' funds indicate insolvency, meaning liabilities exceed assets.
  • Negative net current assets suggest liquidity issues, with short-term obligations exceeding short-term assets.
  • These "symptoms of distress" have persisted over the last four years, indicating chronic financial imbalance.
  • The company's micro-entity accounting regime and unaudited status may limit transparency but do not conceal the fundamental solvency issues.
  • Control is concentrated in a single individual (Sir Peter John Wood), who owns 75-100% shares and voting rights, indicating centralized decision-making.

In medical terms, the company’s "heart" (core financial strength) is weakened by overwhelming "debt burden," and its "circulatory system" (liquidity) is impaired, resulting in poor financial health and risk of collapse without intervention.


4. Recommendations

To improve financial wellness, SPWONE III LTD should consider the following actions:

  1. Debt Restructuring:
    Engage with creditors to negotiate extended repayment terms or debt forgiveness to relieve the heavy leverage "strain" on the balance sheet.

  2. Equity Injection:
    Raise additional share capital or capital contributions from the controlling shareholder or new investors to strengthen the "immune system" (equity base) and reduce insolvency risk.

  3. Asset Utilisation Review:
    Assess the fixed assets for potential sale or better utilisation to generate cash, unlocking "blocked resources" and improving liquidity.

  4. Cash Flow Management:
    Implement tighter short-term cash flow monitoring and management to improve net current assets and avoid liquidity crises.

  5. Financial Reporting Transparency:
    Consider audited financial statements to enhance confidence among stakeholders and enable more informed financial decisions.

  6. Strategic Business Review:
    Evaluate the business model and operational efficiency to improve profitability and reduce reliance on debt financing.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.